ArticleCell death & disease2021

Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer.

Jiawen Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.